Orchid Cellmark, Inc. (ORCH) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-6.21M
Stock-based compensation expense	482K
Depreciation and amortization	2.69M
Provision for losses on accounts receivable	67K
Gain on sale of assets	4K
Accounts receivable	-1.67M
Inventory	-170K
Prepaids and other assets	232K
Accounts payable	752K
Accrued expenses and other current liabilities, including restructuring	254K
Deferred revenue	-34K
Income taxes payable	-467K
Other liabilities	-42K
Net cash (used in) provided by operating activities	-4.11M
Purchases of available-for-sale securities	0
Maturities of available-for-sale securities	3.41M
Capital expenditures	-2.03M
Net cash provided by (used in) investing activities	1.39M
Proceeds from issuance of common stock	74K
Net cash provided by financing activities	74K
Effect of foreign currency translation on cash and cash equivalents	17K
Net decrease in cash and cash equivalents	-2.63M
Cash and cash equivalents at beginning of period	8.11M
Cash and cash equivalents at end of period	5.48M

Entities mentioned with ORCH

View All Entities